查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714626

按產品類型、應用和最終用戶分類的生物資訊市場—2025-2030 年全球預測

Bioinformatics Market by Product Types, Applications, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年生物資訊市場價值將達到 133.3 億美元，2025 年成長至 150 億美元，複合年成長率為 12.97%，到 2030 年將達到 277.2 億美元。

介紹

主要市場統計數據
基準年2024年 133.3億美元
預計2025年 150億美元
預測年份 2030 277.2億美元
複合年成長率（%） 12.97%

在當今快速發展的科技環境中，生物資訊學領域處於創新和顛覆的前沿。隨著生物資料的數量和複雜性不斷增加，該行業正在經歷變革，再形成研究、診斷和藥物開發的過程和結果。這項深入分析全面概況了推動生物資訊學未來發展的市場趨勢、細分策略、關鍵區域和公司洞察。

本報告旨在探討將徹底改變資料擷取、儲存、分析和解釋方式的新技術和創新工具。透過仔細研究最近的趨勢和市場動態，讀者將踏上一段旅程，了解解決複雜生物問題的科學努力如何變得更加全面、精簡和有針對性。本報告說明深入分析和高層次觀點，幫助產業專業人士和策略決策者理解複雜的生物資訊學格局。

本報告的目的是為了解影響市場的關鍵促進因素奠定基礎，並深入了解生物資訊學平台、服務和工具的持續發展。在數位轉型和資料主導決策對科學進步和醫療保健改善至關重要的時代，這種見解尤其重要。讀者將會欣賞這項研究背後嚴謹的方法、明確的發現以及與學術和企業抱負產生共鳴的實際意義。

改變生物資訊市場

生物資訊學領域正在經歷一系列變革時期，重新定義研究和發展的發展方式。運算能力、人工智慧和資料分析的突破性進展不僅提高了生物資料處理的速度和準確性，而且還帶來了整合不同資料集的新方法。雲端處理、機器學習和高通量測序等重大技術創新正在為前所未有的資料整合和解釋水平奠定基礎。

最顯著的變化之一是不同資料源的整合，從基因組學到蛋白質組學到代謝體學。這種整合可以實現複雜的模式識別和預測分析，為藥物發現和臨床診斷提供更有效的途徑。此外，傳統生物分析方法與現代計算技術的結合產生了將手動專業知識與自動化流程相結合的混合系統，從而改善了研究成果。

生物資訊學的數位轉型正在促進更靈活、反應更快的研究環境。資料視覺化工具和即時監控系統的興起使得研究人員能夠以以前無法實現的速度處理大型資料集並獲得可行的見解。因此，市場非常重視互通性，其系統旨在實現無縫通訊並支援跨全球網路的協作計劃。

此外，知識管理的進步對於將複雜的資料集提煉為有意義的情報至關重要。這些變革性轉變不僅代表著技術升級；它們代表了生物學研究概念化和實施方式上的根本性變化。隨著技術創新不斷加速，市場相關人員被迫快速適應以保持競爭力，促使對下一代工具和方法的進一步投資。

關鍵細分洞察

細分分析提供了對生物資訊市場的細緻觀察，重點關注產品類型、應用和最終用戶類別。產品細分涵蓋生物資訊平台、生物資訊服務和知識管理工具。深入挖掘，生物資訊平台進一步使用序列比對平台，序列分析平台，序列操作平台和結構功能分析平台等子區隔進行分析。同樣，與生物資訊服務相關的部分分為資料分析、資料庫管理和定序等領域，每個領域在塑造市場表現和客戶參與方面都發揮著自己的作用。

基於應用的細分突出了農業生物技術、臨床診斷、藥物發現和開發、基因組學以及蛋白質組學和代謝體學等領域的多樣化使用場景。例如，農業生物技術領域從兩個角度進行研究：基因改造生物開發和植物育種工具。在藥物發現和開發領域，分析藥物篩檢和標靶識別等重要方面以揭示潛在的新治療方法。基因組學領域本身已分為兩大陣營：比較基因組學和功能基因組學，凸顯了業界為加強基因分析的比較和應用所做的努力。

根據最終用戶進一步細分顯示，該市場迎合學術和研究機構、農業和環境部門、醫療保健提供者以及製藥和生物技術公司。在學術和研究方面，該分析考慮了研究機構和大學在推動創新和促進教育卓越方面發揮的關鍵作用。在醫療保健領域，診斷中心和醫院之間存在區別，每個中心都有不同的要求和挑戰。這些細分洞察有助於了解不同的客戶需求，並在日益動態的市場環境中發現有針對性的解決方案的機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 提高對生物技術和基因工程應用的認知和接受度
      • 增加政府對基因組研究和生物資訊工具的資助和投入
      • 基因組學在個人化醫療和精準醫療的應用日益廣泛
    • 限制因素
      • 處理敏感遺傳資訊的隱私問題
    • 機會
      • 開發大麻基因組學平台以改善品種選擇和治療應用
      • 拓展生物資訊學在精準醫療的應用，增強個人化治療策略
    • 任務
      • 管理和分析大型資料的複雜性阻礙了研究進展
  • 市場區隔分析
    • 產品類型：擴大採用生物資訊學平台來獲取有意義的生物學見解
    • 最終用戶：醫療保健提供者擴大使用生物資訊學進行個人化醫療和疾病診斷
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 生物資訊市場（依產品類型）

  • 生物資訊平台
    • 序列比對平台
    • 序列分析平台
    • 序列操作平台
    • 結構與功能分析平台
  • 生物資訊服務
    • 資料分析
    • 資料庫管理
    • 定序
  • 知識管理工具

第7章生物資訊市場（按應用）

  • 農業生物技術
    • 基因改造生物的發展
    • 植物育種工具
  • 臨床診斷
  • 藥物研發
    • 藥物檢測
    • 目標識別
  • 基因組學
    • 比較基因組學
    • 功能基因體學
  • 蛋白質體學和代謝體學

第 8 章 生物資訊市場（按最終用戶）

  • 學術研究所
    • 研究部門
    • 大學
  • 農業和環境部門
  • 醫療保健提供者
    • 診斷中心
    • 醫院
  • 製藥和生物技術公司

第9章美洲生物資訊學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物資訊學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 11 章歐洲、中東和非洲生物資訊市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systemes SE
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage-Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen NV
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation
Product Code: MRR-434CCDA04CC1

The Bioinformatics Market was valued at USD 13.33 billion in 2024 and is projected to grow to USD 15.00 billion in 2025, with a CAGR of 12.97%, reaching USD 27.72 billion by 2030.

Introduction

KEY MARKET STATISTICS
Base Year [2024] USD 13.33 billion
Estimated Year [2025] USD 15.00 billion
Forecast Year [2030] USD 27.72 billion
CAGR (%) 12.97%

In today's rapidly evolving scientific and technological environment, the bioinformatics sector is at the forefront of innovation and disruption. With the growing volume and complexity of biological data, the industry is experiencing transformative changes that are reshaping processes and outcomes across research, diagnostics, and drug development. This in-depth analysis provides a comprehensive overview of market trends, segmentation strategies, and key regional and company insights that are driving the future of bioinformatics.

This report embarks on an exploration of emerging technologies and innovative tools that are revolutionizing data acquisition, storage, analysis, and interpretation. Through a careful examination of recent developments and market dynamics, readers are taken on a journey that highlights how scientific endeavors are becoming more integrated, efficient, and targeted in addressing complex biological questions. The discussion that follows offers a blend of detailed analytics and high-level perspectives, thereby serving both industry experts and strategic decision-makers who seek to understand the intricacies of the modern bioinformatics landscape.

The purpose of this report is to create a foundation of understanding regarding the critical drivers influencing the market and to provide insights into the evolving nature of bioinformatics platforms, services, and tools. Such insights are especially important in an era where digital transformation and data-driven decision-making have become central to scientific advancement and healthcare improvements. Readers will appreciate the rigorous methodology behind the research, the clarity of the findings, and the actionable implications that resonate with both academic and corporate ambitions.

Transformative Shifts in the Landscape

The bioinformatics landscape is undergoing a series of transformative shifts that are redefining how research and development are conducted. Groundbreaking advancements in computational power, artificial intelligence, and data analytics have not only improved the speed and accuracy of biological data processing but have also ushered in new methodologies for integrating diverse data sets. Key technological innovations such as cloud computing, machine learning, and high-throughput sequencing are laying the groundwork for unprecedented levels of data integration and interpretation.

One of the most notable shifts is the consolidation of various data sources - from genomics to proteomics and metabolomics. This convergence has enabled complex pattern recognition and predictive analytics, resulting in more efficient pathways for drug discovery and clinical diagnostics. Moreover, the integration of traditional bioanalytical methods with modern computational techniques is giving rise to hybrid systems that combine manual expertise with automated processes, leading to enhanced research outcomes.

Digital transformation in bioinformatics is facilitating a more agile and responsive research environment. With the rise of data visualization tools and real-time monitoring systems, researchers are now better equipped to handle large-scale datasets and draw actionable insights at a speed that was previously unattainable. Consequently, the market has seen a growing emphasis on interoperability, where systems are designed to communicate seamlessly and support collaborative projects across global networks.

Additionally, advancements in knowledge management are proving critical in distilling complex datasets into meaningful intelligence. These transformative shifts are not simply technological upgrades; they represent a fundamental change in the way biological research is conceptualized and executed. As innovation continues to accelerate, market players are compelled to adapt quickly to maintain competitive advantages, driving further investments in next-generation tools and methodologies.

Key Segmentation Insights

The segmentation analysis offers a nuanced view of the bioinformatics market by focusing on product types, applications, and end-user categories. In terms of product segmentation, the market is studied across bioinformatics platforms, bioinformatics services, and knowledge management tools. Delving deeper, the bioinformatics platforms are further analyzed using sub-segments such as sequence alignment platforms, sequence analysis platforms, sequence manipulation platforms, and structural as well as functional analysis platforms. Similarly, the segment pertaining to bioinformatics services is broken down into areas including data analysis, database management, and sequencing, each of which plays a unique role in shaping market performance and customer engagement.

The application-based segmentation highlights the diverse usage scenarios which span areas like agricultural biotechnology, clinical diagnostics, drug discovery and development, genomics, and proteomics and metabolomics. For instance, the agricultural biotechnology segment is explored through the twin lenses of genetically modified organisms development and plant breeding tools. In the realm of drug discovery and development, crucial aspects such as drug screening and target identification are analyzed to capture the robust potential of emerging therapies. The genomics segment itself is bifurcated into comparative genomics and functional genomics, underscoring how the industry is striving to enhance both the comparative and applied aspects of genetic analysis.

Further segmentation based on end-user reveals that the market caters to academic and research institutes, agricultural and environmental sectors, healthcare providers, and pharmaceutical as well as biotechnology companies. In academic and research institutes, the analysis takes into account the roles of both research laboratories and universities, which are pivotal in driving innovation and fostering educational excellence. On the healthcare front, differentiation is made between diagnostic centers and hospitals, as each setting has distinct requirements and challenges. Collectively, these segmentation insights help in understanding the varied customer demands and uncovering opportunities for targeted solutions in an increasingly dynamic market environment.

Based on Product Types, market is studied across Bioinformatics Platforms, Bioinformatics Services, and Knowledge Management Tools. The Bioinformatics Platforms is further studied across Sequence Alignment Platforms, Sequence Analysis Platforms, Sequence Manipulation Platforms, and Structural & Functional Analysis Platforms. The Bioinformatics Services is further studied across Data Analysis, Database Management, and Sequencing.

Based on Applications, market is studied across Agricultural Biotechnology, Clinical Diagnostics, Drug Discovery & Development, Genomics, and Proteomics & Metabolomics. The Agricultural Biotechnology is further studied across GMOs Development and Plant Breeding Tools. The Drug Discovery & Development is further studied across Drug Screening and Target Identification. The Genomics is further studied across Comparative Genomics and Functional Genomics.

Based on End-User, market is studied across Academic & Research Institutes, Agricultural & Environmental Sectors, Healthcare Providers, and Pharmaceutical & Biotechnology Companies. The Academic & Research Institutes is further studied across Research Labs and Universities. The Healthcare Providers is further studied across Diagnostic Centers and Hospitals.

Key Regional Insights

A comprehensive regional analysis reveals that the bioinformatics market is segmented into distinct geographical landscapes, each with its own set of unique opportunities and challenges. In the Americas, market growth is propelled by robust investments in healthcare infrastructure and research innovation. The dynamic nature of the regulatory framework, combined with a strong foundation in academic research and biotechnology, is fostering an environment where advanced bioinformatics tools can thrive. Economic policies and funding initiatives have further reinforced the region's status as a hub for technological advancements and high-end bioinformatics solutions.

When examining the Europe, Middle East & Africa region, a blend of mature market dynamics and emerging technological trends is apparent. European countries, known for their rigorous research standards and integrated healthcare systems, are at the forefront of adopting innovative bioinformatics platforms. Simultaneously, the Middle East and Africa are gradually enhancing their infrastructural capabilities, thereby creating significant opportunities for investments in bioinformatics. This mix of mature and nascent markets calls for tailored strategies that balance advanced technology adoption with the need for infrastructural development and local capacity building.

In the Asia-Pacific, rapid urbanization paired with increasing investments in scientific research is reshaping the bioinformatics landscape. The area is witnessing accelerated adoption of advanced sequencing technologies, cloud-based analytics, and automated solutions, which have a profound impact on both clinical diagnostics and agricultural biotechnology. This region's focus on innovation is further boosted by government initiatives and private sector investments, ensuring that bioinformatics remains a pivotal element of the overall digital transformation strategy. The contrasting market maturity levels across these regions highlight the diverse challenges and opportunities present in a globally interconnected marketplace.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

The bioinformatics market is characterized by the presence of several prominent players that are instrumental in driving industry evolution and setting new standards in innovation. Leading companies, including 10x Genomics, Inc., Agilent Technologies, Inc., and BGI Group, have been at the forefront of technological advancements, continually offering cutting-edge platforms and services that address the complex needs of modern biological research. Further reinforcing market dynamics, Bio-Rad Laboratories, Inc. and BioDiscovery Group have mastered the integration of analytical tools with high-throughput processing capabilities, thereby influencing both clinical and research applications.

Other significant contributors such as biomodal Limited and Dassault Systemes S.E. have expanded their footprints by developing innovative software solutions that enhance data visualization and management across multiple bioinformatics applications. Companies like DNASTAR, Inc. and Eurofins Genomics LLC focus on providing specialized analytical services that cater to the growing demand for precise and reproducible results in genetic research and clinical diagnostics. Industry leaders like F. Hoffmann-La Roche Ltd. and Genevia Technologies Oy are well-regarded for their robust research and development capabilities, which in turn drive greater efficiency and accuracy in data analysis protocols.

The landscape further benefits from the presence of emerging innovators such as Genomics Ltd., HaploX, and Illumina, Inc., each of which brings a unique perspective by harnessing the power of next-generation sequencing and other advanced analytical techniques. Integrated DNA Technologies, Inc. and Labcorp Genetics Inc. continue to refine sequencing services, ensuring that both the scale and scope of data processing are aligned with evolving research demands. Additionally, contributions from Labvantage - Biomax GmbH, Novo Nordisk A/S, and Oxford Nanopore Technologies plc. have created pathways for enhancing the overall efficiency of bioinformatics applications.

The market is further enriched by the participation of Pacific Biosciences of California, Inc., Partek Incorporated, PerkinElmer, Inc., Qiagen N.V., RIKEN GENESIS CO.,LTD., SOPHiA GENETICS SA, Telesis Bio Inc., Thermo Fisher Scientific Inc., Veracyte, Inc., and Waters Corporation. These companies, through their relentless pursuit of innovation and excellence, continue to raise the bar for product development, service excellence, and technological integration, thereby underpinning a competitive and forward-looking market environment.

The report delves into recent significant developments in the Bioinformatics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., BioDiscovery Group, biomodal Limited, Dassault Systemes S.E., DNASTAR, Inc., Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd, Genevia Technologies Oy, Genomics Ltd., HaploX, Illumina, Inc., Integrated DNA Technologies, Inc., Labcorp Genetics Inc., Labvantage - Biomax GmbH, Novo Nordisk A/S, Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., Partek Incorporated, PerkinElmer, Inc., Qiagen N.V., RIKEN GENESIS CO.,LTD., SOPHiA GENETICS SA, Telesis Bio Inc., Thermo Fisher Scientific Inc., Veracyte, Inc., and Waters Corporation. Actionable Recommendations for Industry Leaders

For decision-makers and market strategists, the key to leveraging competitive advantage in the bioinformatics sector lies in fostering innovation, optimizing technological integration, and aligning offerings with evolving customer needs. Leaders are advised to invest in research and development, particularly in areas that integrate advanced data analytics with automated sequencing and structural analysis. It is essential to focus on developing hybrid systems that blend traditional methodologies with modern computational capabilities. This approach not only improves accuracy but also enhances the speed at which complex biological datasets are interpreted.

Building strategic alliances with technology innovators and research institutions can accelerate the adoption of new platforms. Industry players should seek partnerships that enable access to state-of-the-art tools and facilitate knowledge sharing across various scientific domains. In parallel, efforts should be made to streamline regulatory compliance and ensure that data security measures are robust, given the sensitivity of biological and patient data.

Another focal point is the exploration of untapped regional markets. As emerging economies invest heavily in infrastructure and digital transformation, expanding into these regions can offer substantial growth opportunities. Tailoring strategies that address localized needs while leveraging global expertise can provide a sustainable competitive edge. Additionally, diversifying product portfolios to include both hardware and software solutions in bioinformatics will cater to the increasingly sophisticated demands of end-users and help capture a broader market share.

Future-proofing investment decisions remains critical. Leaders must continuously monitor technological advances and market trends to preempt disruptive changes. Embracing a culture of agility-where products and services can be rapidly adapted to changing scenarios-will be vital in maintaining relevance. In summary, actionable recommendations focus on enhancing innovation pipelines, forging strategic collaborations, expanding into new geographical territories, and adopting flexible business models that can withstand the dynamic nature of the bioinformatics landscape.

Conclusion

In conclusion, the bioinformatics market is presently experiencing a period of dynamic transformation driven by rapid technological advancements and integrated data analysis methods. Through a detailed examination of market segmentation, regional influences, and key players, the current landscape emerges as both highly complex and filled with opportunity. The sector's evolution is propelled by a confluence of advanced computational tools, innovative product offerings, and a deepening understanding of biological complexities.

The insights provided in this report underscore the importance of a multi-faceted approach to market strategy, one that seamlessly blends technological innovation with clear, actionable business strategies. By embracing digital transformation and leveraging state-of-the-art analytical methods, industry stakeholders have the opportunity to drive significant breakthroughs in research and healthcare delivery. Moreover, the comprehensive analysis of segmentation and regional trends paves the way for more targeted investments and enhanced market positioning.

Ultimately, as the bioinformatics market continues to expand and mature, the integration of diverse technological advancements with robust analytical frameworks will determine the future trajectory of the industry. Stakeholders who remain agile and forward-thinking are well poised to capitalize on emerging trends and contribute to the evolution of this critical field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of biotechnology and genetic engineering applications
      • 5.1.1.2. Increasing government funding and initiatives for genomic research and bioinformatics tools
      • 5.1.1.3. Growing adoption of personalized medicine and precision healthcare applications in genomics
    • 5.1.2. Restraints
      • 5.1.2.1. Privacy concerns associated with the handling of sensitive genetic information
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing bioinformatics platforms for cannabis genomics to improve strain selection and therapeutic use
      • 5.1.3.2. Expanding the application of bioinformatics in precision medicine to enhance personalized treatment strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in managing and analyzing large-scale datasets hinders research progress
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Types: Growing adoption of bioinformatics platforms to derive meaningful biological insights
    • 5.2.2. End-User: Rising utilization of bioinformatics in healthcare providers for personalized medicine and disease diagnosis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioinformatics Market, by Product Types

  • 6.1. Introduction
  • 6.2. Bioinformatics Platforms
    • 6.2.1. Sequence Alignment Platforms
    • 6.2.2. Sequence Analysis Platforms
    • 6.2.3. Sequence Manipulation Platforms
    • 6.2.4. Structural & Functional Analysis Platforms
  • 6.3. Bioinformatics Services
    • 6.3.1. Data Analysis
    • 6.3.2. Database Management
    • 6.3.3. Sequencing
  • 6.4. Knowledge Management Tools

7. Bioinformatics Market, by Applications

  • 7.1. Introduction
  • 7.2. Agricultural Biotechnology
    • 7.2.1. GMOs Development
    • 7.2.2. Plant Breeding Tools
  • 7.3. Clinical Diagnostics
  • 7.4. Drug Discovery & Development
    • 7.4.1. Drug Screening
    • 7.4.2. Target Identification
  • 7.5. Genomics
    • 7.5.1. Comparative Genomics
    • 7.5.2. Functional Genomics
  • 7.6. Proteomics & Metabolomics

8. Bioinformatics Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
    • 8.2.1. Research Labs
    • 8.2.2. Universities
  • 8.3. Agricultural & Environmental Sectors
  • 8.4. Healthcare Providers
    • 8.4.1. Diagnostic Centers
    • 8.4.2. Hospitals
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas Bioinformatics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioinformatics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioinformatics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Solis Agrosciences enhances bioinformatics capabilities with acquisition of Ferris Genomics platform to boost agriculture innovation
    • 12.3.2. Seqera unveils AWS-backed containers to streamline bioinformatics research and foster innovation
    • 12.3.3. Metabolon launches advanced bioinformatics platform enhancing precision in metabolomics research
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. BGI Group
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioDiscovery Group
  • 6. biomodal Limited
  • 7. Dassault Systemes S.E.
  • 8. DNASTAR, Inc.
  • 9. Eurofins Genomics LLC
  • 10. F. Hoffmann-La Roche Ltd
  • 11. Genevia Technologies Oy
  • 12. Genomics Ltd.
  • 13. HaploX
  • 14. Illumina, Inc.
  • 15. Integrated DNA Technologies, Inc.
  • 16. Labcorp Genetics Inc.
  • 17. Labvantage - Biomax GmbH
  • 18. Novo Nordisk A/S
  • 19. Oxford Nanopore Technologies plc.
  • 20. Pacific Biosciences of California, Inc.
  • 21. Partek Incorporated
  • 22. PerkinElmer, Inc.
  • 23. Qiagen N.V.
  • 24. RIKEN GENESIS CO.,LTD.
  • 25. SOPHiA GENETICS SA
  • 26. Telesis Bio Inc.
  • 27. Thermo Fisher Scientific Inc.
  • 28. Veracyte, Inc.
  • 29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOINFORMATICS MARKET MULTI-CURRENCY
  • FIGURE 2. BIOINFORMATICS MARKET MULTI-LANGUAGE
  • FIGURE 3. BIOINFORMATICS MARKET RESEARCH PROCESS
  • FIGURE 4. BIOINFORMATICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOINFORMATICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOINFORMATICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ALIGNMENT PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE MANIPULATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATABASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY GMOS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY PLANT BREEDING TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOINFORMATICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOINFORMATICS MARKET SIZE, BY COMPARATIVE GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOINFORMATICS MARKET SIZE, BY PROTEOMICS & METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOINFORMATICS MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOINFORMATICS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL & ENVIRONMENTAL SECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOINFORMATICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOINFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOINFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 338. NIGERIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 339. NIGERIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY BIOINFORMATICS MARKET SIZE, BY